BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.250
-0.060 (-4.58%)
At close: Dec 24, 2025, 1:00 PM EST
1.270
+0.020 (1.58%)
After-hours: Dec 24, 2025, 4:22 PM EST
BioVie Market Cap
BioVie has a market cap or net worth of $9.57 million as of December 24, 2025. Its market cap has decreased by -82.04% in one year.
Market Cap
9.57M
Enterprise Value
-15.07M
1-Year Change
-82.04%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $9.57M, a decrease of -81.59%. That is a compound annual growth rate of -27.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 9.90M | -72.11% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |